Andrew Kei-Yan Ng

7PUBLICATIONS
9CO-AUTHORS
Molecular targetsCardiology (incl. cardiovascular diseases)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 24, 2024
Atherothrombotic Outcomes After Sodium-Glucose Cotransporter 2 Inhibitors Versus Dipeptidyl Peptidase-4 Inhibitors in Patients With Type 2 Diabetes: A Territory-Wide Retrospective Cohort Study.

Pauline Yeung Ng, Andrew Kei-Yan Ng, April Ip

|Oct 07, 2023
Clinical Outcomes of Left Atrial Appendage Occlusion Versus Switch of Direct Oral Antcoagulant in Atrial Fibrillation: A Territory-Wide Retrospective Analysis.

Andrew Kei-Yan Ng, Pauline Yeung Ng, April Ip

|Sep 30, 2023
Ticagrelor was associated with lower fracture risk than clopidogrel in the dual anti-platelet regimen among patients with acute coronary syndrome treated with percutaneous coronary intervention.

D T W Lui, C H Wong, A Ip

|Mar 10, 2022
Risk of ischaemic and haemorrhagic stroke in Chinese undergoing percutaneous coronary intervention treated with potent P2Y12 inhibitor versus clopidogrel.

Andrew Kei-Yan Ng, Pauline Yeung Ng, April Ip

|Feb 11, 2022
Impact of contrast-induced acute kidney injury on long-term major adverse cardiovascular events and kidney function after percutaneous coronary intervention: insights from a territory-wide cohort study in Hong Kong.

Andrew Kei-Yan Ng, Pauline Yeung Ng, April Ip

|Jan 12, 2022
Trade-off of major bleeding versus myocardial infarction on mortality after percutaneous coronary intervention.

Andrew Kei-Yan Ng, Pauline Yeung Ng, April Ip

Pageof 2

Frequent Collaborators

2 joint publications

Pauline Yeung Ng

2 joint publications

April Ip

1 joint publications

D T W Lui

1 joint publications

Raymond Chi-Yan Fung